Deals
Deals dated after 30 September 2026 are still being collected.
Columns
3 of 3 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2026 | Nuvalent | – | GSK | Acquisition | Legal adviser to GSK (acquirer) | Pending | 10,600.0 | Biotech+2 | Leerink Partners (buy-side)Citi (buy-side)Davis Polk (buy-side)Centerview Partners (sell-side)Ropes & Gray (sell-side)Jefferies (sell-side)Sidley Austin (sell-side)Innisfree M&A (buy-side)Sullivan & Cromwell | GSK acquisition of Nuvalent |
| Mar 2026 | The Economist Group | Lady Lynn Forester de Rothschild, her family and the ERANDA Rothschild Foundation | Stephen Smith | Stake | Legal adviser to Smith Financial (acquirer) | Completed | – | Media & Entertainment+1 | Freshfields (sell-side)Barclays (buy-side)Lazard (sell-side) | Stephen Smith stake in The Economist Group |
| Feb 2026 | atNorth | Partners Group | Canada Pension Plan Investment Board | Acquisition | Legal adviser to Equinix (acquirer) | Completed | 4,000.0 | Data Centers | Guggenheim Securities (buy-side) | Canada Pension Plan Investment Board acquisition of atNorth |
Activity
By announcement date; raisings and IPOs by their own date.
Sector of the business bought or funded.
Disclosed value in US dollars.
Most often across the table
- Centerview Partners
1 dealCompare - Ropes & Gray1 dealCompare
- Jefferies
1 dealCompare - Sidley Austin
1 dealCompare - Freshfields1 dealCompare
- Lazard
1 dealCompare
Firms advising the other side of the same deals.